Spinal Tech

Intuitive Surgical announced its founding partnership in the American Hernia Society Quality Collaborative.

The Nasdaq Listings Qualifications department sent Amedica a letter saying the minimum bid price per share for its common stock was below $1 for 30 consecutive business days, meaning the company didn't meet the minimum bid price required in the…

Aurora Spine completed the first trache of common share non-brokered private placement.

Amedica's stock price rose 23.08 percent last week, although the bid price remains under $1, which could be problematic for the company to remain listed, according to a Winston View report.

A young patient has successfully used Celltex Therapeutics to culture and bank his own stem cells to be for use in treating his severe case of systemic juvenile idiopathic arthritis.

Misonix CEO Michael A. McManus, Jr., has been selected as a top CEO at a micro-cap company for 2014 by ExecRank.

Anika Therapeutics appointed Glenn R. Larsen, PhD, as a new independent member of its board of directors.

OrthAlign announced that Gary D. Henley will join its board of directors as executive chairman.

DJO Global reported net sales growth during the fourth quarter of 2014, as well as for the full year, but also posted a net loss.

Vertex Pharmaceuticals recently acquired a spinal cord injury repair drug from BioAxome Bioseicneces, which could be the company's saving grace after the hepatitis C drug Vertex took a gamble on failed, according to an Xconomy report.